Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicholas Navin

Showing results (21-30 of 51) with videos related to

Pageof 6
Sort By:
Biorxiv : the Preprint Server for Biology|September 24, 2024
Single cell genome and epigenome co-profiling reveals hardwiring and plasticity in breast cancerKaile Wang, Yun Yan, Heba Elgamal, et al.
Nature|March 15, 2011
Tumour evolution inferred by single-cell sequencingNicholas Navin, Jude Kendall, Jennifer Troge, et al.
Genome Research|November 12, 2009
Inferring tumor progression from genomic heterogeneityNicholas Navin, Alexander Krasnitz, Linda Rodgers, et al.
Genome Biology|November 15, 2022
MEDICC2: whole-genome doubling aware copy-number phylogenies for cancer evolutionTom L Kaufmann, Marina Petkovic, Thomas B K Watkins, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 29, 2026
Systemic immune correlates of long-term survival after Delta-24-RGD based on the Therapeutic Adenovirus for Recurrent Glioblastoma Effect Trial (TARGET)Chibawanye I Ene, Sanjay Singh, Thiagarajan Venkataraman, et al.
Cell Genomics|November 24, 2022
Spatial intra-tumor heterogeneity is associated with survival of lung adenocarcinoma patientsHua-Jun Wu, Daniel Temko, Zoltan Maliga, et al.
Science (New York, N.Y.)|July 27, 2004
Large-scale copy number polymorphism in the human genomeJonathan Sebat, B Lakshmi, Jennifer Troge, et al.
Nature Biotechnology|August 17, 2023
Single-nucleotide variant calling in single-cell sequencing data with MonopogenJinzhuang Dou, Yukun Tan, Kian Hong Kock, et al.
Nature|November 20, 2024
Normal breast tissues harbour rare populations of aneuploid epithelial cellsYiyun Lin, Junke Wang, Kaile Wang, et al.
The Lancet. Oncology|September 14, 2019
Cabazitaxel plus carboplatin for the treatment of men with metastatic castration-resistant prostate cancers: a randomised, open-label, phase 1-2 trialPaul G Corn, Elisabeth I Heath, Amado Zurita, et al.
Pageof 6

Showing results (21-30 of 51) with videos related to

Sort By:
Pageof 6
Biorxiv : the Preprint Server for Biology|September 24, 2024
Single cell genome and epigenome co-profiling reveals hardwiring and plasticity in breast cancerKaile Wang, Yun Yan, Heba Elgamal, et al.
Nature|March 15, 2011
Tumour evolution inferred by single-cell sequencingNicholas Navin, Jude Kendall, Jennifer Troge, et al.
Genome Research|November 12, 2009
Inferring tumor progression from genomic heterogeneityNicholas Navin, Alexander Krasnitz, Linda Rodgers, et al.
Genome Biology|November 15, 2022
MEDICC2: whole-genome doubling aware copy-number phylogenies for cancer evolutionTom L Kaufmann, Marina Petkovic, Thomas B K Watkins, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 29, 2026
Systemic immune correlates of long-term survival after Delta-24-RGD based on the Therapeutic Adenovirus for Recurrent Glioblastoma Effect Trial (TARGET)Chibawanye I Ene, Sanjay Singh, Thiagarajan Venkataraman, et al.
Cell Genomics|November 24, 2022
Spatial intra-tumor heterogeneity is associated with survival of lung adenocarcinoma patientsHua-Jun Wu, Daniel Temko, Zoltan Maliga, et al.
Science (New York, N.Y.)|July 27, 2004
Large-scale copy number polymorphism in the human genomeJonathan Sebat, B Lakshmi, Jennifer Troge, et al.
Nature Biotechnology|August 17, 2023
Single-nucleotide variant calling in single-cell sequencing data with MonopogenJinzhuang Dou, Yukun Tan, Kian Hong Kock, et al.
Nature|November 20, 2024
Normal breast tissues harbour rare populations of aneuploid epithelial cellsYiyun Lin, Junke Wang, Kaile Wang, et al.
The Lancet. Oncology|September 14, 2019
Cabazitaxel plus carboplatin for the treatment of men with metastatic castration-resistant prostate cancers: a randomised, open-label, phase 1-2 trialPaul G Corn, Elisabeth I Heath, Amado Zurita, et al.
Pageof 6